Notice of Intent to Sole Source – Metabolon Inc.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) intends to award a fixed-price sole source purchase order to Metabolon, Inc. for biological sample testing services. This acquisition supports a diet intervention clinical research trial at the NIH Clinical Center in Bethesda, MD. This is a Notice of Intent, not a request for quotation, and a solicitation will not be issued. Interested parties may submit their capabilities by May 13, 2026, at 1 PM EST.
Purpose & Scope
The NIH requires specialized biological sample testing for a diet intervention clinical research trial. Metabolon, Inc. is identified as the sole source due to its unique expertise in bioanalysis and data interpretation of metabolomics, superior analytical and bioinformatics technologies, and high-throughput workflow. Their proprietary bioinformatics technology is critical for rapidly sorting biochemical data. Furthermore, Metabolon has previously analyzed samples for this study, and using the same vendor is essential to limit variability and allow for consistent data comparison with similar clinical trials.
Contract Details
This is a fixed-price purchase order intended for sole source award to Metabolon, Inc. The acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, specifically Subpart 13.106-1(b)(1), which allows for soliciting from a single source when the contracting officer determines only one source is reasonably available for purchases not exceeding the simplified acquisition threshold. Contracts under FAR Part 13 are exempt from FAR Part 6 competition requirements.
Set-Aside
None specified.
Response Information
This is a notice of intent only; a solicitation will not be issued, and quotations are not being requested. However, interested parties may identify their interest and capabilities in response to this posting. The government retains sole discretion regarding the decision not to compete the requirement based on responses.
Timeline & Contact
- Published Date: May 6, 2026
- Response Due: May 13, 2026, 1 PM EST
- Contact: Kristin Nagashima (kristin.nagashima@nih.gov)